Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy

PURPOSE: The efficacy of entecavir (ETV) versus tenofovir (TDF) on the prognosis of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients who underwent FOLFOX-hepatic arterial infusion chemotherapy (HAIC) remains unclear. In this study, we compared the outcomes between ETV and TDF...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhikai, Wang, Jiongliang, Wu, Tianqing, He, Minrui, Wang, Juncheng, Pan, Yangxun, Chen, Jinbin, Hu, Dandan, Xu, Li, Zhang, Yaojun, Chen, Minshan, Zhou, Zhongguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695128/
http://dx.doi.org/10.2147/JHC.S436062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695128/
http://dx.doi.org/10.2147/JHC.S436062

Ejemplares similares